NEW POLL: Overwhelming majority of Americans oppose efforts to weaken Bayh-Dole Act, misuse as price control mechanism

News

23 Mar Moderna Exec Stands By COVID-19 Vaccine Price Increase

Posted at 14:18h Other Media

Adam Lidgett
Law360, 3/22/2023...

23 Mar After Xtandi, Will Government Ever Seek March-In Rights Over Drug Pricing?

Posted at 14:16h Other Media

Brenda Sandburg
The Pink Sheet, 3/22/2023...

22 Mar NIH rejects bid to cut a cancer drug’s price by sidestepping patents

Posted at 09:08h Other Media

Ed Silverman
STAT, 3/22/2023...

22 Mar Moderna Confronts ‘Poster Child’ Label as Price Crackdown Looms

Posted at 09:05h Other Media

Alex Ruoff
Bloomberg Government, 3/22/2023...

21 Mar Bayh-Dole Coalition Statement on NIH Rejection of Xtandi March-in Petition

Posted at 18:35h Press Releases

WASHINGTON, D.C. (March 21, 2023) --Today, in response to the NIH's just-announced decision to reject activists' requests for the federal government to misuse "march-in" rights under the Bayh-Dole Act against the successfully developed prostate cancer drug Xtandi, Executive Director of the Bayh-Dole Coalition Joseph P. Allen released the following statement: ...